Literature DB >> 15099766

Rapid screening for HLA-B27 by a TaqMan-PCR assay using sequence-specific primers and a minor groove binder probe, a novel type of TaqMan trade mark probe.

Sylvain Kuzio1, Kuzio Sylvain, Aurélie Hanguehard, Hanguehard Aurélie, Marc Morelle, Morelle Marc, Christophe Ronsin, Ronsin Christophe.   

Abstract

HLA-B27 is strongly associated with ankylosing spondylitis (AS). As typing for HLA-B27 is routinely performed by serological methods, false-positive results can be generated. Therefore, several more accurate molecular methods have been developed for HLA-B27 genotyping. We describe a real-time PCR method for the detection of the HLA-B27 allele using sequence-specific primers (SSP) combined with a fluorogenic MGB probe (minor groove binder probe), a novel type of TaqMan probe. The MGB increases the melting temperature (T(m)) of the probe, allowing the use of shorter probes. Moreover, the use of a non-fluorescent quencher (NFQ) attached to the MGB probe improves the efficiency of fluorescence quenching, thus providing a very low fluorescent background. We tested this method on 150 subjects (41 HLA-B27 positive and 109 HLA-B27 negative) who underwent routine HLA-B27 serological testing by flow cytometry (FC). Serology and our TaqMan assay gave identical results in all cases and no false positive or negative results were observed. A graphical representation of fluorescence and normalized reporter signal (DeltaRn) values demonstrated that HLA-B27 positive and HLA-B27 negative samples formed two tight clusters making it possible to clearly differentiate between HLA-B27 positive and negative samples. This single tube PCR method for the detection of HLA-B27 should be particularly suitable for the routine analysis of large numbers of samples in the laboratory.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099766     DOI: 10.1016/j.jim.2004.01.027

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

Review 1.  HLA testing in the molecular diagnostic laboratory.

Authors:  Kathleen Madden; Devon Chabot-Richards
Journal:  Virchows Arch       Date:  2018-12-04       Impact factor: 4.064

2.  Simultaneous genotyping of DRB1/3/4/5 loci by oligonucleotide microarray.

Authors:  Ye Bang-Ce; Chu Xiaohe; Fan Ye; Li Songyang; Yin Bincheng; Zuo Peng
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

3.  IL6 genotype and creatine kinase response to exercise.

Authors:  Jani Lappalainen
Journal:  Eur J Appl Physiol       Date:  2009-04-08       Impact factor: 3.078

4.  A real-time PCR approach for rapid high resolution subtyping of HLA-DRB1*04.

Authors:  Vivian H Gersuk; Gerald T Nepom
Journal:  J Immunol Methods       Date:  2006-10-02       Impact factor: 2.303

5.  A real-time polymerase chain reaction assay for the rapid identification of the autoimmune disease-associated allele HLA-DQB1*0602.

Authors:  V H Gersuk; G T Nepom
Journal:  Tissue Antigens       Date:  2009-04

6.  Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients.

Authors:  Katri Saukkonen; Päivi Lakkisto; Marjut Varpula; Tero Varpula; Liisa-Maria Voipio-Pulkki; Ville Pettilä; Kari Pulkki
Journal:  Intensive Care Med       Date:  2007-05-31       Impact factor: 17.440

7.  Rapid identification and quantification of Campylobacter coli and Campylobacter jejuni by real-time PCR in pure cultures and in complex samples.

Authors:  Mily Leblanc-Maridor; François Beaudeau; Henri Seegers; Martine Denis; Catherine Belloc
Journal:  BMC Microbiol       Date:  2011-05-22       Impact factor: 3.605

8.  Genetic determinants of cocaine-associated agranulocytosis.

Authors:  Jane A Buxton; John Omura; Margot Kuo; Colin Ross; Despina Tzemis; Roy Purssell; Jennifer Gardy; Bruce Carleton
Journal:  BMC Res Notes       Date:  2015-06-13

9.  Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays.

Authors:  Giulia Breveglieri; Anna Travan; Elisabetta D'Aversa; Lucia Carmela Cosenza; Patrizia Pellegatti; Giovanni Guerra; Roberto Gambari; Monica Borgatti
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.